HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hemolytic uremic syndrome: an example of insufficient complement regulation on self-tissue.

Abstract
Hemolytic uremic syndrome (HUS) is a triad of microangiopathic hemolytic anemia, thrombocytopenia, and acute renal failure. HUS is classified as either diarrhea associated, most commonly caused by infection with Escherichia coli O157, or the less common atypical HUS (aHUS), which may be familial or sporadic. Approximately 50% of patients with aHUS have mutations in one of the complement control proteins: factor H, factor I, or membrane cofactor protein (MCP). These proteins regulate complement activation through cofactor activity, the inactivation of C3b by limited proteolytic cleavage, a desirable event in the fluid phase (no target) or on healthy self-tissue (wrong target). Complement activation follows the endothelial cell injury that characterizes HUS. This disease represents a model of what takes place when inappropriate complement activation occurs on self-tissues due to the presence of mutated complement regulatory proteins. Screening for mutations in factor H, factor I, or MCP is expensive and time consuming. One approach is to perform antigenic screening for factor H and factor I deficiency and to look for low levels of MCP (CD46) expression by flow cytometry. Complement regulatory protein deficiency impacts treatment decisions as patients with aHUS have a recurrence rate in renal transplants of approximately 50%, whereas those with factor H mutations have an even higher risk (approximately 80%). By contrast, MCP deficiency can be corrected in part by a renal allograft. However, caution in the use of live-related donations is needed because of the high rates of incomplete penetrance of the described mutations.
AuthorsJohn P Atkinson, M Kathryn Liszewski, Anna Richards, David Kavanagh, Elizabeth A Moulton
JournalAnnals of the New York Academy of Sciences (Ann N Y Acad Sci) Vol. 1056 Pg. 144-52 (Nov 2005) ISSN: 0077-8923 [Print] United States
PMID16387683 (Publication Type: Journal Article, Review)
Chemical References
  • Membrane Cofactor Protein
  • Complement C3b
  • Complement System Proteins
Topics
  • Complement Activation
  • Complement C3b (physiology)
  • Complement System Proteins (physiology)
  • Escherichia coli Infections (complications)
  • Hemolytic-Uremic Syndrome (microbiology, physiopathology)
  • Homeostasis
  • Humans
  • Membrane Cofactor Protein (genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: